Evidence map›Paper›PMID 30451858›Full record

ArticleNature communications2018

Signal peptide represses GluK1 surface and synaptic trafficking through binding to amino-terminal domain.

Gui-Fang Duan, Yaxin Ye, Sha Xu, Wucheng Tao, Shiping Zhao, Tengchuan Jin, Roger A Nicoll, Yun Stone Shi, Nengyin Sheng

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Gui-Fang DuanState Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology, Nanjing Drum Tower Hospital, The Affliated Hospital of Nanjing University Medical School, and Minister of Education Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Nanjing, 210032, China.
Yaxin YeState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China.
Sha XuState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China.
Wucheng TaoDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, 94143, CA, USA.
Shiping ZhaoState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China.
Tengchuan JinHefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, 230007, China.ORCID http://orcid.org/0000-0002-1395-188X
Roger A NicollDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, 94143, CA, USA.
Yun Stone ShiState Key Laboratory of Pharmaceutical Biotechnology, Department of Neurology, Nanjing Drum Tower Hospital, The Affliated Hospital of Nanjing University Medical School, and Minister of Education Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Nanjing, 210032, China. yunshi@nju.edu.cn.ORCID http://orcid.org/0000-0002-8842-9818
Nengyin ShengState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China. shengnengyin@mail.kiz.ac.cn.ORCID http://orcid.org/0000-0003-3086-3950
Kunming Institute of Zoology · CNUniversity of California, San Francisco · USNanjing Brain Hospital · CNNanjing Drum Tower Hospital · CNUniversity of Science and Technology of China · CN

Funding

Synaptic Plasticity Regulated by Stargazin-like gamma-8R01MH070957 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NICOLL, ROGER A · 2004 to 2019
$6.3M
NIMH NIH HHS R01 MH070957
6 · The paper itself

Abstract

Kainate-type glutamate receptors play critical roles in excitatory synaptic transmission and synaptic plasticity in the brain. GluK1 and GluK2 possess fundamentally different capabilities in surface trafficking as well as synaptic targeting in hippocampal CA1 neurons. Here we find that the excitatory postsynaptic currents (EPSCs) are significantly increased by the chimeric GluK1(SP

Indexed as

AnimalsAnimals, NewbornBinding SitesCA1 Region, HippocampalExcitatory Postsynaptic PotentialsGene ExpressionGluK2 Kainate ReceptorGreen Fluorescent ProteinsHEK293 CellsHemagglutininsHumansKainic Acid ReceptorsMicrotomyMutant Chimeric ProteinsNeuronal PlasticityOrgan Culture TechniquesGluK2 Kainate ReceptorGreen Fluorescent ProteinsHemagglutininsKainic Acid ReceptorsMutant Chimeric ProteinsProtein Sorting Signals

Identifiers

PMID30451858
PMCPMC6242971
OpenAlexW2900834943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.